One in three women diagnosed with MS will subsequently conceive, therefore consideration of the maternal-infant dyad is ...

NEW YORK, April 10, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), announced the presentation of data yesterday highlighting BRIUMVI ® (ublituximab-xiiy) in patients with relapsing ...

Fibrobiologics' cell therapy CYMS101 significantly increased myelin production and promoted myelin repair in a mouse model of ...

Detailed price information for Tg Therapeutics (TGTX-Q) from The Globe and Mail including charting and trades.

No added benefits in slowing MS disability progression were found in a study that increased Ocrevus dosing to 2-3 times the ...

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, ...

The actress boosts awareness of MS as the West Hollywood-based neurologist works to limit its effect on patients ...

TG Therapeutics (TGTX) announced the publication of two journal articles one describing the evolution of CD20 treatments for multiple sclerosis ...

TG Therapeutics (TGTX) announced the presentation of data highlighting BRIUMVI in patients with relapsing forms of multiple sclerosis, at the ...

A British couple fear deportation by the Australian government after being diagnosed with MS, which has led authorities to ...

by infusion or intravenously, or via subcutaneous injection – is an issue with this disease. “Poor adherence to disease-modifying drug treatment in multiple sclerosis remains a challenge in ...